Phytochemicals and metabolic disorders: managing diabetes, obesity, and metabolic syndrome
Authors:
- Uma Maheshwari SrinivasaUSUma Maheshwari Srinivasa
- Paramasivan KalaivaniPKParamasivan Kalaivani
- Rani Elavarasan AnithaRARani Elavarasan Anitha
- 13 September 2025
- book chapter
- Published by Elsevier
- p. 235-259
Abstract
No abstract availableThis publication has 167 references indexed in Scilit:
- Harnessing Phytochemicals to Regulate Catalytic Residues of Alpha-Amylase and Alpha-Glucosidase in Type 2 DiabetesCell Biochemistry and Biophysics, 2024
- A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetesPhytochemistry Reviews, 2021
- Phytochemicals against anti‐diabetic complications: targeting the advanced glycation end product signaling pathwayArchives of Pharmacal Research, 2021
- Role of plant-derived alkaloids against diabetes and diabetes-related complications: a mechanism-based approachPhytochemistry Reviews, 2019
- Pharmacotherapy of Obesity: Limits and PerspectivesAmerican Journal of Cardiovascular Drugs, 2019
- Recent advances in the pathogenesis of microvascular complications in diabetesArchives of Pharmacal Research, 2019
- Interaction of antidiabetic α‐glucosidase inhibitors and gut bacteria α‐glucosidaseProtein Science, 2018
- AMPK activation by prolonged stimulation with interleukin‐1β contributes to the promotion of GLUT4 translocation in skeletal muscle cellsCell Biology International, 2016
- Potential agents for cancer and obesity treatment with herbal medicines from the green gardenBiotechnology and Bioprocess Engineering, 2011
- Terpenes: substances useful in human healthcareArchivum Immunologiae et Therapiae Experimentalis, 2007